Literature DB >> 7043186

Glucose intolerance in liver cirrhosis.

O Riggio, M Merli, C Cangiano, R Capocaccia, A Cascino, A Lala, F Leonetti, M Mauceri, M Pepe, F Rossi Fanelli, M Savioli, G Tamburrano, L Capocaccia.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 7043186     DOI： 10.1016/0026-0495(82)90103-2

Source DB:  PubMed          Journal:  Metabolism        ISSN： 0026-0495            Impact factor:   8.694


× No keyword cloud information.
  15 in total

Review 1.  Interaction between hepatitis C virus and metabolic factors.

Authors:  Yasunori Kawaguchi; Toshihiko Mizuta
Journal:  World J Gastroenterol       Date:  2014-03-21       Impact factor: 5.742

2.  Hyperproinsulinaemia in cirrhosis.

Authors:  R Taylor; K G Alberti
Journal:  Diabetologia       Date:  1984-05       Impact factor: 10.122

3.  Hyperaminoacidaemia reduces insulin-mediated glucose disposal in healthy man.

Authors:  P Tessari; S Inchiostro; G Biolo; E Duner; R Nosadini; A Tiengo; G Crepaldi
Journal:  Diabetologia       Date:  1985-11       Impact factor: 10.122

4.  Insulin binding to erythrocytes in hyperinsulinemic patients with precirrhotic hemochromatosis and cirrhosis.

Authors:  A S Petrides; W Passlack; H Reinauer; W Stremmel; G Strohmeyer
Journal:  Klin Wochenschr       Date:  1987-09-15

5.  Resistance to insulin suppression of plasma free fatty acids in liver cirrhosis.

Authors:  M Merli; F Leonetti; O Riggio; A Giaccari; A Romiti; P Sbraccia; G Tamburrano
Journal:  J Endocrinol Invest       Date:  1990-11       Impact factor: 4.256

6.  Mechanisms of hyperinsulinaemia in Child's disease grade B liver cirrhosis investigated in free living conditions.

Authors:  A V Greco; G Mingrone; A Mari; E Capristo; M Manco; G Gasbarrini
Journal:  Gut       Date:  2002-12       Impact factor: 23.059

7.  Correction of altered plasma amino acid pattern in cirrhosis of the liver by somatostatin.

Authors:  B Limberg; B Kommerell
Journal:  Gut       Date:  1984-11       Impact factor: 23.059

8.  In vivo insulin action in hepatocellular and cholestatic liver cirrhosis.

Authors:  N Barzilai; P Cohen; E Karnieli; R Enat; O Epstein; J Owen; N McIntyre
Journal:  J Endocrinol Invest       Date:  1991-10       Impact factor: 4.256

9.  The development of diabetes mellitus and chronic liver disease in long term chelated beta thalassaemic patients.

Authors:  V De Sanctis; G D'Ascola; B Wonke
Journal:  Postgrad Med J       Date:  1986-09       Impact factor: 2.401

10.  Mechanism of insulin resistance in human liver cirrhosis. Evidence of a combined receptor and postreceptor defect.

Authors:  P Cavallo-Perin; M Cassader; C Bozzo; A Bruno; P Nuccio; A M Dall'Omo; M Marucci; G Pagano
Journal:  J Clin Invest       Date:  1985-05       Impact factor: 14.808
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.